Skip to content

NuytsTech Security

  • Home
  • Terms of Use
    • Privacy Policy
  • Blog
  • Cloud Hosting
  • Contact

NuytsTech Security

  • Home
  • Terms of Use
    • Privacy Policy
  • Blog
  • Cloud Hosting
  • Contact
  • Vulnerabilities

CVE-2021-25920

by Fred · 22/03/2021

In OpenEMR, versions v2.7.2-rc1 to 6.0.0 are vulnerable to Improper Access Control when creating a new user, which leads to a malicious user able to read and send sensitive messages on behalf of the victim user.

Date published : 2021-03-22

https://github.com/openemr/openemr/commit/0fadc3e592d84bc9dfe9e0403f8bd6e3c7d8427f

https://www.whitesourcesoftware.com/vulnerability-database/CVE-2021-25920

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Bluesky (Opens in new window) Bluesky
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Mastodon (Opens in new window) Mastodon

Similar

Tags: Cybersecurity Alert

  • Next story CVE-2020-12483
  • Previous story CVE-2021-28961

Recent Posts

  • CVE-2025-6081
  • CVE-2025-5967
  • CVE-2025-6940
  • CVE-2025-6939
  • CVE-2025-6938
  • CVE-2025-53096
  • CVE-2025-53095
  • CVE-2025-53003
  • CVE-2025-6937
  • CVE-2025-53005
  • CVE-2025-36056
  • CVE-2025-2141
  • CVE-2025-6936
  • CVE-2025-6935
  • CVE-2025-6932
  • CVE-2025-6931
  • CVE-2025-6930
  • CVE-2025-6554
  • CVE-2025-6929
  • CVE-2025-53004
  • CVE-2025-49521
  • CVE-2025-49520
  • CVE-2025-32463
  • CVE-2025-32462
  • CVE-2025-52997
  • CVE-2025-52996
  • CVE-2025-52995
  • CVE-2025-52901
  • CVE-2025-52491
  • CVE-2025-49493

Categories

  • Critical cyberalert
  • Vulnerabilities

Tags

CISA Cybersecurity Alert Shields Up

© 1999-2025 NUYTSTECH. All Rights Reserved. Use of the CVE (Common Vulnerabilities and Exposures) from this non-profit website are subject to the terms of use.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.